KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) has 137 institutional investors that have filed 13F reports for the period ending June 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Venrock Adviser, LLC | 31 Mar, 2026 | 6,474,485 | -254,500 | -3.78% | $130,331,383.00 |
| Frazier Life Sciences Management, L.P. | 31 Mar, 2026 | 4,961,108 | -78,759 | -1.56% | $99,867,104.00 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 4,768,712 | 0 | 0.00% | $95,994,173.00 |
| TANG CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 4,573,530 | 0 | 0.00% | $92,065,159.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 3,795,897 | 41,749 | 1.11% | $76,411,406.00 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,876,407 | 449,289 | 18.51% | $57,902,073.00 |
| Capital World Investors | 31 Mar, 2026 | 2,808,583 | 0 | 0.00% | $56,536,776.00 |
| Point72 Asset Management, L.P. | 31 Mar, 2026 | 2,136,940 | -146,826 | -6.43% | $43,016,602.00 |
| State Street Corp | 31 Mar, 2026 | 1,955,844 | 44,153 | 2.31% | $39,371,140.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 1,912,146 | -984,520 | -33.99% | $38,491,499.00 |
| Vestal Point Capital, LP | 31 Mar, 2026 | 1,850,000 | -40,000 | -2.12% | $37,240,500.00 |
| Parkman Healthcare Partners LLC | 31 Mar, 2026 | 1,835,506 | 1,835,506 | 0.00% | $36,948,736.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,830,467 | 1,830,467 | 0.00% | $36,847,301.00 |
| Kynam Capital Management, LP | 31 Mar, 2026 | 1,820,954 | 10,000 | 0.55% | $36,655,804.00 |
| Woodline Partners LP | 31 Mar, 2026 | 1,509,920 | -411,172 | -21.40% | $30,394,690.00 |
| Octagon Capital Advisors LP | 31 Mar, 2026 | 1,450,000 | 176,667 | 13.87% | $29,188,500.00 |
| EMERALD ADVISERS, LLC | 31 Mar, 2026 | 1,264,023 | -76,472 | -5.70% | $25,444,783.00 |
| ARMISTICE CAPITAL, LLC | 31 Mar, 2026 | 1,236,000 | 436,000 | 54.50% | $24,880,680.00 |
| Elmind Capital, LP | 31 Mar, 2026 | 1,021,300 | 220,000 | 27.46% | $20,558,769.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 996,235 | 52,158 | 5.52% | $20,059,823.00 |